Skip to content
ppharmaranks
Menu

Best Topoisomerase Inhibitor for lung neoplasms

The 2 Topoisomerase Inhibitor options we list for lung neoplasms are all Etoposide— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for lung neoplasms or the full Topoisomerase Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 2 topoisomerase inhibitor drugs we rate for lung neoplasms, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for lung neoplasms; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

How topoisomerase inhibitor work

Topoisomerase inhibitors target enzymes that cells rely on to cut and rejoin their DNA during cell division. By trapping these enzymes after they cut the DNA but before they can reseal it, the drugs leave the DNA broken, which halts cell division and kills rapidly dividing cancer cells.

Source: Topoisomerase Inhibitors - LiverTox - NCBI Bookshelf

These are all Etoposidein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.

All 2 topoisomerase inhibitor products

Frequently asked

What is the best topoisomerase inhibitor for lung neoplasms?
The Topoisomerase Inhibitor options we list for lung neoplasms are all Etoposide — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
Which topoisomerase inhibitor drugs treat lung neoplasms?
pharmaranks lists 2 Topoisomerase Inhibitor products used for lung neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.